Remedium Retatrutide 30mg Pen is a next-generation GLP-1/GIP/GCGR receptor agonist formulated for advanced metabolic and weight-management research. Designed in a convenient prefilled pen format, this product delivers precise dosing with enhanced user control and consistency.
Retatrutide is recognised for its multi-pathway mechanism, supporting appetite regulation, metabolic efficiency, and fat utilisation. The Remedium pen format offers accuracy, reduced preparation time, and improved handling compared to traditional vial systems. – Remedium Retatrutide 30mg Pen
Key Features
-
30mg Retatrutide per prefilled pen
-
Triple-agonist metabolic research compound
-
Precision dosing delivery system
-
Manufactured under controlled laboratory conditions
-
Designed for advanced research and investigational use
How It Works
Retatrutide targets GLP-1, GIP, and glucagon receptors, working synergistically to regulate appetite signals, enhance metabolic output, and influence energy balance. This triple-pathway action makes it distinct from single or dual agonist compounds.
How to Use
-
Administer according to structured research protocols
-
Pen format allows controlled and measured dosing
-
Not intended for human therapeutic use
Who It’s For
-
Advanced metabolic research
-
GLP-1 focused investigational studies
-
Professionals seeking pen-based delivery accuracy
Storage & Quality
-
Store refrigerated as recommended
-
Do not freeze
-
Protect from light
